Showing results (431-440 of 459) with videos related to

Sort By:
Pageof 46
Nature|January 20, 2022
Enantiomer-dependent immunological response to chiral nanoparticlesLiguang Xu, Xiuxiu Wang, Weiwei Wang, et al.
AIDS (London, England)|August 11, 2020
Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational studyAlexy Inciarte, Ana Gonzalez-Cordon, Jhon Rojas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2026
Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results from the VOLVER Clinical TrialMaría De Lagarde, Rosa De Miguel, Mayra A Sigcha, et al.
Clinical Drug Investigation|May 21, 2011
Clinical utility of maravirocJorge Parra, Joaquín Portilla, Federico Pulido, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 2023
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life settingAlba Rocabert, Beatriz Borjabad, Leire Berrocal, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2026
Short-cycle three-day-per-week efavirenz/emtricitabine/tenofovir disoproxil fumarate therapy: a seven-year extension studyBeatriz Borjabad, Jhon Rojas, Alexy Inciarte, et al.
PLOS Global Public Health|February 14, 2025
International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreakVanessa Apea, Boghuma K Titanji, Francesca H Dakin, et al.
The Journal of Clinical Investigation|September 22, 2022
Neonatal hyperoxia in mice triggers long-term cognitive deficits via impairments in cerebrovascular function and neurogenesisMarissa A Lithopoulos, Xavier Toussay, Shumei Zhong, et al.
Infectious Diseases and Therapy|July 26, 2023
Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective StudyLorena De La Mora, Cristina Pitart, Laura Morata, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2009
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP studyJosep Mallolas, Daniel Podzamczer, Ana Milinkovic, et al.
Pageof 46